BONIVA vs RISEDRONATE SODIUM

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. BONIVA and RISEDRONATE SODIUM are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BONIVA	RISEDRONATE SODIUM
Rating	New	56/100
Pharmacy pays	$2.81 /mL	~$73.02 /30
Type	RX	RX
Active ingredient	IBANDRONATE SODIUM	RISEDRONATE SODIUM
Manufacturer	Hoffmann La Roche	Teva
Dosage forms	Tablet, Injectable	Tablet, delayed release
Drug class	Bisphosphonate	Bisphosphonate
Boxed warning	None	None
Half-life	—	about 561 hours — roughly 23 days
Treats	Postmenopausal Osteoporosis	Extramammary Paget Disease, Postmenopausal Osteoporosis

boniva risedronate sodium

Rating

New

56/100

Pharmacy pays

$2.81 /mL

~$73.02 /30

Type

Active ingredient

IBANDRONATE SODIUM

RISEDRONATE SODIUM

Manufacturer

Hoffmann La Roche

Teva

Dosage forms

Tablet, Injectable

Tablet, delayed release

Drug class

Bisphosphonate

Boxed warning

None

Half-life

—

about 561 hours — roughly 23 days

Treats

Postmenopausal Osteoporosis

Extramammary Paget Disease, Postmenopausal Osteoporosis

Frequently asked questions

What is the difference between Boniva and Risedronate Sodium?

Boniva contains Ibandronate Sodium, while Risedronate Sodium contains Risedronate Sodium — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.